Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 90
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02278575 | Atenativ Effect on Uterine Blood Flow and Preeclampsia | ||
| NCT03793426 | Safety and Efficacy of Fibryga in Congenital Fibrinogen Deficiency | ||
| NCT02256917 | Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A | ||
| NCT02962765 | Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ | ||
| NCT02972281 | Systematic Search for Primary Immunodeficiency in Adults With Infections | ||
| NCT04354129 | Observational Study of Subcutaneous Immunoglobulin (Cutaquig) in Patients With Primary and Secondary Immunodeficiency. | ||
| NCT02875236 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81) | ||
| NCT03939533 | Study to Monitor Subcutaneous Human Immunoglobulin Administered at Modified Dosing Regimens in Patients With Primary Immunodeficiency Diseases | ||
| NCT04640142 | Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases | ||
| NCT03907241 | CLINICAL PHASE III STUDY TO MONITOR THE SAFETY, TOLERABILITY AND EFFICACY OF SUBCUTANEOUS HUMAN IMMUNOGLOBULIN (OCTANORM) IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY DISEASES, INCLUDING (BUT NOT LIMITED TO) THOSE WHO HAVE COMPLETED THE SCGAM-01 TRIAL | ||
| NCT01012323 | A Study of NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases | ||
| NCT03686969 | Study Evaluating Efficacy and Safety of Octanorm in Patients With Dermatomyositis | ||
| NCT04502030 | Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) | ||
| NCT04046848 | Safety and Pharmacokinetics of Subcutaneous Injection of OCTA101 in Adult Patients With Severe Hemophilia A | ||
| NCT02408484 | Study to Assess the Efficacy, Safety and Pharmacokinetic of Octafibrin in Paediatric Subjects With Fibrinogen Deficiency | ||
| NCT05936580 | Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery | ||
| NCT02111590 | Immunoglobulin Dosage and Administration Form in CIDP and MMN | ||
| NCT04867837 | Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor | ||
| NCT01712438 | Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients | ||
| NCT03695978 | Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients | ||
| NCT01938404 | Octaplas Adult TTP Trial | ||
| NCT04411667 | Study of SOC Plus IVIG Compared to SOC Alone in the Treatment of COVID-19 | ||
| NCT00811174 | Efficacy, Safety and Kinetics Study of Octagam 10% in Primary Immunodeficiency Diseases | ||
| NCT03348618 | A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) | ||
| NCT05523297 | Active-control Randomized Trial Comparing 4-factor Prothrombin Complex Concentrate With Frozen Plasma in Cardiac Surgery | ||
| NCT03866798 | Study to Evaluate the Efficacy and Safety of PANZYGA in Pediatric Patients With Chronic Immune Thrombocytopenia (ITP) | ||
| NCT01341912 | Study to Investigate the Long-term Efficacy and Safety of Human-cl rhFVIII in Previously Treated Patients (PTPs) | ||
| NCT03092245 | Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock (SHOCK) Trial | ||
| NCT04153422 | IVIG in the Treatment of Autoimmune Small Fiber Neuropathy With TS-HDS, FGFR-3, or Plexin D1 Antibodies | ||
| NCT02115503 | A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients | ||
| NCT01225276 | Safety and Efficacy Study of Three Different Dosages of NewGam in Patients With CIDP | ||
| NCT04651400 | Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection | ||
| NCT06096116 | Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | ||
| NCT04023019 | Treatment of Hemophilia A Patients With FVIII Inhibitors | ||
| NCT04106895 | Use of Fibryga, a Fibrinogen Concentrate in Real World: Retrospective Collection of Clinical Data | ||
| NCT03344003 | Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq | ||
| NCT02638207 | Study to Evaluate Safety and Efficacy of Three Different Dosages of NewGam in Patients With Chronic Inflammatory Demyelinating Poly (Radiculo) Neuropathy | ||
| NCT02037373 | Evaluation of the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation | ||
| NCT04508530 | Phase III Study To Compare The Effect of Panzyga Versus Placebo in Patients With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS/PANDAS) | ||
| NCT01063595 | A Trial to Investigate the Relative Efficacy, Safety, and Tolerability of Octaplas LG Versus Octaplas SD | ||
| NCT02303093 | Non-Interventional Study on the Tolerability and Efficacy of IVIG | ||
| NCT04953884 | Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age | ||
| NCT04106908 | Effectiveness and Tolerability of Eqwilate in Real-life Conditions | ||
| NCT01365546 | Wilate in Subjects With Von Willebrand Disease Who Undergo Surgery | ||
| NCT00618098 | Study of Octaplex (Human Prothrombin Complex Concentrate) and Fresh Frozen Plasma in Patients Under Vitamin K Therapy Antagonist Needing Urgent Surgery or Invasive Procedures | ||
| NCT03656640 | Trial Assessing Safety and Efficacy of Gammanorm® in Autoimmune Diseases | ||
| NCT01602419 | Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease | ||
| NCT03385395 | Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency | ||
| NCT02954575 | Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A | ||
| NCT03369301 | The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency |
